EXICURE, INC. current report, 14 December 2021

Business Context and Reporting Period

Company: Exicure, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 14, 2021
Event: Entry into a Material Definitive Agreement for a Registered Direct Offering.

Key Financial Metrics and Transaction Details

This filing details a capital raise rather than operational financial results. Key transaction metrics include:

  • Gross Proceeds: Approximately $11.5 million.
  • Net Proceeds: Approximately $10.2 million (after fees and expenses).
  • Securities Issued:
    • 13,006,614 shares of Common Stock.
    • 21,569,454 Pre-Funded Warrants.
    • 17,288,034 Warrants.
  • Pricing:
    • Combined price per Common Stock share and Warrant: $0.3326.
    • Combined price per Pre-Funded Warrant and Warrant: $0.3316.
    • Warrant Exercise Price: $0.2701 per share.
  • Placement Agent Fees: 7.5% cash fee plus 1.0% management fee of gross proceeds.

Material Changes and Use of Proceeds

The filing does not report operational changes or comparative financial periods. The primary material change is the increase in capital and potential dilution from the issuance of new securities. The Company plans to use the net proceeds for working capital and general corporate purposes.

Outlook, Risks, and Unusual Items

  • Closing Date: Expected on or about December 16, 2021, subject to customary conditions.
  • Warrant Terms: Warrants are immediately exercisable (from December 16, 2021) and expire on December 16, 2026. They include a cashless exercise provision if the registration statement is not effective.
  • Ownership Limits: Pre-Funded Warrants were issued to prevent a purchaser from exceeding 4.99% (or 9.99% at election) beneficial ownership.
  • Emerging Growth Company: The Company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

Investor Verification Checklist

  • Verify the actual closing date and final net proceeds received.
  • Confirm the total number of outstanding shares post-offering to assess dilution impact.
  • Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and termination provisions.
  • Monitor the Company's cash burn rate to determine how long the $10.2 million in net proceeds will sustain operations.
  • Check for any subsequent filings regarding the exercise of Pre-Funded Warrants or Warrants.